OKYO Pharma (OKYO) Total Debt (2023 - 2025)
OKYO Pharma (OKYO) posted quarterly Total Debt of $185795.0 for Q3 2025, up 10176.27% year-over-year from N/an in Q3 2024, and down 78.38% quarter-over-quarter from $859325.0 in Q1 2025.
OKYO Pharma (OKYO) Total Debt (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has reported Total Debt for 3 consecutive years, with $185795.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Debt rose 10176.27% year-over-year to $185795.0; the TTM figure through Sep 2025 stood at $185795.0 (up 10176.27% YoY), while the FY2025 annual figure was $859325.0, up 139.56% from the prior year.
- Total Debt fell to $185795.0 in Q3 2025 per OKYO's latest filing, from $859325.0 in the prior quarter.
- Across five years, Total Debt topped out at $859325.0 in Q1 2025 and bottomed at $1808.0 in Q3 2024.
- Historically, Total Debt has averaged $384836.6 across 3 years, with a median of $358709.0 in 2024.
- Annual changes were most pronounced in 2024 — Total Debt sank 99.65% — and 2025, when it soared 10176.27%.
- OKYO Pharma's Total Debt stood at $518546.0 in 2023, then tumbled by 99.65% to $1808.0 in 2024, then jumped by 10176.27% to $185795.0 in 2025.
- Business Quant data shows OKYO's Total Debt at $185795.0 in Q3 2025, $859325.0 in Q1 2025, and $1808.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | OKYO Pharma | 1.52 Bn | 1.52 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 185,795.00 |
| Mar 31, 2025 | 859,325.00 |
| Sep 30, 2024 | 1,808.00 |
| Mar 31, 2024 | 358,709.00 |
| Sep 30, 2023 | 518,546.00 |